Quick Takeaways Why It Matters? The partnership deepens Wagmo’s value proposition by bundling tangible smart devices with its insurance and wellness offerings, making plans more “sticky” and differentiated versus traditional pet insurers. By extending GPS and ac...
Quick Takeaways: Why It Matters? APVMA approval gives Elanco a timely first international expansion for Credelio Quattro under the Advocate franchise, letting it leverage strong brand equity to capture share in Australia’s highly competitive, vet‑d...
Quick Takeaways: Why It Matters? The EUAs immediately expand the therapeutic toolkit for a serious, fast-moving parasitic threat, positioning NexGard and NexGard COMBO as go‑to options if New World screwworm spreads beyond current foci in northern Mexico.&nb...
Quick Takeaways Why It Matters? The partnership allows GekkoVet to scale rapidly in a new geography by leveraging Royal Canin’s established veterinary relationships, positioning its AI platform as an embedded part of day-to-day clinical practice. For R...
Quick Takeaways: Why It Matters? BE-101’s move into pivotal field safety testing brings the poultry sector closer to a commercially viable, non-antibiotic solution for necrotic enteritis, addressing a major economic and welfare burden while aligning with global pressure to...
Quick Takeaways Why It Matters? The merger creates one of the most integrated players in animal health, combining physical distribution, practice software, and pharmacy services into a single, tech-enabled platform that can embed itself deeply in veterinary workflows. Vet...
Quick Takeaways Why It Matters? CompanAIn taps into the growing demand for continuous, between-visit pet health management, positioning itself as a data hub that complements rather than replaces veterinary care. By unifying home observations with medical and lab data...
Quick Takeaways: Why It Matters? Full approval elevates KBroVet from a conditional option to the reference standard for potassium bromide in canine idiopathic epilepsy, giving vets greater confidence in its long‑term use. Its once‑daily, chewable, liver...
Quick Takeaways Why It Matters? Loyal’s raise reinforces longevity as a serious, institution-backed frontier in veterinary medicine, moving it from niche concept to an emerging preventive care category. If LOY-002 secures conditional and then full approval, it could...
Quick Takeaways: Why It Matters? MUMS status gives Masivet a clearer US regulatory and commercial path, adding potential 7‑year market exclusivity and grant support on top of its established European use, which should enhance the asset’s value as AB Science courts par...
